Despite recent advances in immunotherapy and targeted therapy,the mortality rate seen in lung cancer(LC)is the highest of all cancer forms.The recent topical coronavirus disease 19(COVID-19)and its subsequent pandemic...Despite recent advances in immunotherapy and targeted therapy,the mortality rate seen in lung cancer(LC)is the highest of all cancer forms.The recent topical coronavirus disease 19(COVID-19)and its subsequent pandemic have resulted in over 505 million confirmed cases and approxi-mately 6.2 million fatalities as of April 2022,1 with a stag-gering 30%e50%mortality rate seen in LC patients with COVID-19.2 Cancer patients,in particular,are highly vulnerable to COVID-19 infection due to immunosuppression.展开更多
基金supported by the Medical Research Council(UK)(No.MR/S025480/1)an Academy of Medical Sciences/the Wellcome Trust Springboard Award(UK)(No.SBF002\1038).
文摘Despite recent advances in immunotherapy and targeted therapy,the mortality rate seen in lung cancer(LC)is the highest of all cancer forms.The recent topical coronavirus disease 19(COVID-19)and its subsequent pandemic have resulted in over 505 million confirmed cases and approxi-mately 6.2 million fatalities as of April 2022,1 with a stag-gering 30%e50%mortality rate seen in LC patients with COVID-19.2 Cancer patients,in particular,are highly vulnerable to COVID-19 infection due to immunosuppression.
